[BNews]

Featured Articles

Ethereum Price Eyes $2.6K as Transfer Activity Hits New High

Should You Buy BYD Before or After China’s Auto Market Implodes?

The Israeli startup aiming to become the “Tesla of trains”

A New Wave of Functional Wellness Products – A massive Market and Investment Opportunity

ANALYSIS | SpaceX wants to launch a million satellites. Here’s how that could impact us here on Earth

Amazon Stock Decline 2026: High Put Premiums Create Trading Opportunities – News and Stati

Apple stock in focus as AI-spending nerves grow — what to watch when AAPL trading returns

Ethereum Price Eyes $2.6K as Transfer Activity Hits New High

Should You Buy BYD Before or After China’s Auto Market Implodes?

The Israeli startup aiming to become the “Tesla of trains”

A New Wave of Functional Wellness Products – A massive Market and Investment Opportunity

ANALYSIS | SpaceX wants to launch a million satellites. Here’s how that could impact us here on Earth

Amazon Stock Decline 2026: High Put Premiums Create Trading Opportunities – News and Stati

Apple stock in focus as AI-spending nerves grow — what to watch when AAPL trading returns

Featured STOCK

  • [Gasgoo Express] NIO’s William Li Discusses ES9 Design, Saying Originality is Difficult bu

    Gasgoo Edited by Betty From Gasgoo|April 11 , 2026 14:33 BJT Automaker Trends | OEM News IT Home: On April 9, NIO founder, chairman, and CEO William Li wrote about original design. He believes that as the creator of a new category of intelligent electric executive flagship SUVs, the NIO ES9 requires pioneering technology. Li...

  • B Capital By AMED To Support Japan Drug Development Ecosystem

      B Capital announced it has been selected as a registered venture capital firm under the Agency for Medical Research and Development’s Strengthening Program for Pharmaceutical Startup Ecosystem, positioning the firm to expand its investment and commercialization efforts across Japan’s pharmaceutical and biotech startup landscape. The designation enables B Capital to invest in drug discovery...

  • B Capital By AMED To Support Japan Drug Development Ecosystem

      B Capital announced it has been selected as a registered venture capital firm under the Agency for Medical Research and Development’s Strengthening Program for Pharmaceutical Startup Ecosystem, positioning the firm to expand its investment and commercialization efforts across Japan’s pharmaceutical and biotech startup landscape. The designation enables B Capital to invest in drug discovery...